| Dr Sharon Uralil, DO | |
|
550 1st Ave, New York, NY 10016-6402 | |
| (212) 263-3293 | |
| Not Available |
| Full Name | Dr Sharon Uralil |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 550 1st Ave, New York, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003044017 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 270096 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York University Langone Medical Center | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
News Archive
Immunotherapy drugs such as PD-L1 checkpoint inhibitors represent the front-line treatment for kidney cancer. But immunotherapy is expensive, benefits only a subset of patients and is futile in the majority of patients.
As our brains age, we become more forgetful, more tired and less able to do the cognitive gymnastics of our youth.
Alcoholic beverages popular among youths are more likely to be advertised in magazines with high youth readership than alcoholic drinks consumed mainly by adults, resulting in disproportionately high youth exposure to such targeted alcohol ads, according to a new study.
Fero Industries, Inc. is pleased to announce that it has closed the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.
› Verified 4 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
Immunotherapy drugs such as PD-L1 checkpoint inhibitors represent the front-line treatment for kidney cancer. But immunotherapy is expensive, benefits only a subset of patients and is futile in the majority of patients.
As our brains age, we become more forgetful, more tired and less able to do the cognitive gymnastics of our youth.
Alcoholic beverages popular among youths are more likely to be advertised in magazines with high youth readership than alcoholic drinks consumed mainly by adults, resulting in disproportionately high youth exposure to such targeted alcohol ads, according to a new study.
Fero Industries, Inc. is pleased to announce that it has closed the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.
› Verified 4 days ago
| Entity Name | New York Queens Medicine And Surgery, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003114851 PECOS PAC ID: 4082883673 Enrollment ID: O20110817000163 |
News Archive
Immunotherapy drugs such as PD-L1 checkpoint inhibitors represent the front-line treatment for kidney cancer. But immunotherapy is expensive, benefits only a subset of patients and is futile in the majority of patients.
As our brains age, we become more forgetful, more tired and less able to do the cognitive gymnastics of our youth.
Alcoholic beverages popular among youths are more likely to be advertised in magazines with high youth readership than alcoholic drinks consumed mainly by adults, resulting in disproportionately high youth exposure to such targeted alcohol ads, according to a new study.
Fero Industries, Inc. is pleased to announce that it has closed the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sharon Uralil, DO 5645 Main St, Flushing, NY 11355-5045 Ph: () - | Dr Sharon Uralil, DO 550 1st Ave, New York, NY 10016-6402 Ph: (212) 263-3293 |
News Archive
Immunotherapy drugs such as PD-L1 checkpoint inhibitors represent the front-line treatment for kidney cancer. But immunotherapy is expensive, benefits only a subset of patients and is futile in the majority of patients.
As our brains age, we become more forgetful, more tired and less able to do the cognitive gymnastics of our youth.
Alcoholic beverages popular among youths are more likely to be advertised in magazines with high youth readership than alcoholic drinks consumed mainly by adults, resulting in disproportionately high youth exposure to such targeted alcohol ads, according to a new study.
Fero Industries, Inc. is pleased to announce that it has closed the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.
› Verified 4 days ago
Dr. Ravishankar Ramaswamy, MD, MS Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1440 Madison Avenue, New York, NY 10029 Phone: 212-659-8552 Fax: 212-860-9737 | |
Dr. Pietro Alessandro Ambrogio Canetta, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 622 W 168th St, Ph4-124, New York, NY 10032 Phone: 212-305-5020 Fax: 212-305-6692 | |
Dr. Rakhshan Mahmood Chida, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 327 E 17th St, New York, NY 10003 Phone: 212-420-5690 | |
Charles D Resor, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 622 W 168th St, New York, NY 10032 Phone: 212-305-2913 | |
Dr. Jacqueline Yuey Lonier, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1150 Saint Nicholas Ave, New York, NY 10032 Phone: 212-851-5494 | |
Diana Kantor, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 775 9th Ave, New York, NY 10019 Phone: 212-586-1550 |